Condition: Adenocarcinoma of the Rectum · Sponsor: Imperial College London
Any patient with a suspected primary adenocarcinoma of the colon, sigmoid or rectum undergoing surgery are eligible. The date of surgery must be known prior to registration. This trial aims to determine if image mapping techniques can improve the concordance between imaging and pathology detection of tumour deposits. Lymph nodes and tumour deposits will be identified on pre-operative scans and mapped by radiologists then shared with pathologists prior to processing the resected specimen. Patients will be managed at their local hospital with standard follow-up. Patients will be followed up for 5 years.
This description comes directly from the study's public registry record.
Caroline Martin · +44 (0) 7749 655 817 · c.martin1@imperial.ac.uk
Syvella Ellis · +44 (0) 7732 315 234 · giclinicaltrials@imperial.ac.uk
Always discuss trial participation with your own doctor first.
| Royal Marsden Hospital NHS Foundation Trust | London, Surrey, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03303547